Morris, Ceri A., El-Hiti, Gamal A., Weeks, Ian  ORCID: https://orcid.org/0000-0002-6362-2929, Woodhead, Stuart, Smith, Keith and Kille, Peter  ORCID: https://orcid.org/0000-0001-6023-5221
      2017.
      
      Quantitative analysis of gene expression changes in response to genotoxic compounds.
      Toxicology in Vitro
      39
      
      , pp. 15-28.
      
      10.1016/j.tiv.2016.11.004
    
  
  
         | 
      
Preview  | 
          
            
PDF
 - Accepted Post-Print Version
   Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (906kB) | Preview  | 
        
Abstract
Techniques that quantify molecular endpoints sufficiently sensitive to identify and classify potentially toxic compounds have wide potential for high-throughput in vitro screening. Expression of three genes, RAD51C, TP53 and cystatin A (CSTA), in HEPG2 cells was measured by Q-PCR amplification. In parallel, we developed alternative assays for the same 3 gene signature based on an acridinium-ester chemiluminescent reporter molecule. HEPG2 cells were challenged with eighteen different compounds (n = 18) chosen to represent compounds that are genotoxic (n = 8), non-genotoxic non-carcinogenic (n = 2) or have a less well defined mechanism of action with respect to genotoxicity (n = 8). At least one of the three genes displayed dysregulated expression in the majority of compounds tested by Q-PCR and ten compounds changed the CSTA expression significantly. Acridinium-ester labelled probes for the three genes were synthesised and tested. Analytical sensitivity was characterised and suggested a limit of detection generally better than 0.1 fmol but often 10–50 attomol. A linear amplification step was optimised and this quantitative method detected statistically significant increases in RAD51C and CSTA expression in agreement with the Q-PCR results, demonstrating the potential of this technology. The broad agreement of the amplified chemiluminescent method and Q-PCR in measuring gene expression suggests wider potential application for this chemiluminescent technology.
| Item Type: | Article | 
|---|---|
| Date Type: | Publication | 
| Status: | Published | 
| Schools: | Schools > Biosciences Schools > Chemistry Schools > Medicine  | 
      
| Subjects: | R Medicine > R Medicine (General) | 
| Uncontrolled Keywords: | Acridinium-ester; Chemiluminescence; Genotoxic; Cystatin A (CSTA); RAD51C; Tumour suppressor p53 (TP53) | 
| Publisher: | Elsevier | 
| ISSN: | 0887-2333 | 
| Funders: | Welsh Government | 
| Date of First Compliant Deposit: | 22 November 2016 | 
| Date of Acceptance: | 2 November 2016 | 
| Last Modified: | 12 Nov 2024 04:30 | 
| URI: | https://orca.cardiff.ac.uk/id/eprint/96347 | 
Actions (repository staff only)
![]()  | 
              Edit Item | 

							



 Altmetric
 Altmetric